Serial nutritional screening with MUST or SaskIBD-NR significantly enhances the specificity of malnutrition risk detection in IBD patients in remission, supporting the incorporation of repeated nutritional assessments into clinical practice.
Key Findings
Results
Malnutrition prevalence in IBD patients in sustained clinical remission increased substantially over six months.
At baseline, 25.7% of patients were malnourished according to ESPEN criteria, 9% per GLIM criteria, and 7.5% exhibited low FFMI.
After six months, malnutrition prevalence increased to 53% per ESPEN criteria, 16.6% per GLIM criteria, and 16.6% for low FFMI.
The study enrolled 66 IBD patients (32 Crohn's disease; 34 ulcerative colitis) in a prospective, single-center cohort design.
All patients were in sustained clinical remission at enrollment.
Results
MUST and SaskIBD-NR consistently exhibited the highest specificity for malnutrition detection among the five nutritional screening tools evaluated.
MUST and SaskIBD-NR showed the highest specificity at baseline, at 6 months, and for persistent malnutrition across ESPEN, GLIM, and low FFMI reference standards.
Five nutritional screening tools (NSTs) were compared: MUST, SaskIBD-NR, and three others not individually named in the abstract.
Tools were evaluated for sensitivity, specificity, predictive values, and accuracy at both time points.
Results
Serial (repeated) administration of nutritional screening tools markedly improved specificity compared to single-point assessments.
The improvement in specificity was observed across all five nutritional screening tools when administered serially versus at a single time point.
Serial assessments were performed at baseline and after six months.
This improvement was demonstrated using ESPEN criteria, GLIM criteria, and low FFMI as reference standards.
A sensitivity analysis using low FFMI as a reference standard was performed to validate findings.
Background
Malnutrition is frequently under-investigated during remission in IBD patients despite its significant impact on clinical outcomes and quality of life.
The study was motivated by the gap in nutritional monitoring during IBD remission phases.
Body composition analysis was performed alongside NST administration at both time points.
The study used both ESPEN and GLIM diagnostic criteria as reference standards for malnutrition.
Fat-free mass index (FFMI) was used as an additional reference measure for body composition-based malnutrition detection.
Methods
The study was designed as a prospective, single-center cohort study administering five nutritional screening tools at two time points six months apart.
NSTs and body composition analysis were performed at baseline and after six months in IBD outpatients.
Sensitivity, specificity, predictive values, and accuracy of NSTs were evaluated at both time points.
Repeated assessments were compared to single-point assessments for diagnostic performance.
A sensitivity analysis using low FFMI as a reference was also performed in addition to ESPEN and GLIM criteria comparisons.
Favale A, Orrù V, Lutzu N, Di Petrillo A, Demurtas M, Ibba I, et al.. (2026). Optimizing Malnutrition Risk Detection in Inflammatory Bowel Disease: A Longitudinal Analysis of Serial Nutritional Screening Tools.. Nutrients. https://doi.org/10.3390/nu18030383